AMGEN INC: Ariad’s Appeal to Patent Breach Ruling Denied in June

Subscribe
TOPICS: Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: California | United States